MHC class II restricted tumor antigens and the role of CD4+ T cells in cancer immunotherapy

Research output: Contribution to journalArticlepeer-review

Abstract

Recent studies in human and murine systems suggest a central role for CD4+ T cells in initiating, effecting and maintaining anti-tumor immunity. Characterization of the tumor-associated antigens recognized by CD4+ T cells may prove critical to the success of cancer immunotherapy strategies.

Original languageEnglish (US)
Pages (from-to)741-745
Number of pages5
JournalCurrent Opinion in Immunology
Volume6
Issue number5
DOIs
StatePublished - 1994
Externally publishedYes

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Fingerprint Dive into the research topics of 'MHC class II restricted tumor antigens and the role of CD4<sup>+</sup> T cells in cancer immunotherapy'. Together they form a unique fingerprint.

Cite this